Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

Veru's enobosarm shows safety when combined with Wegovy, Advanz-Alvotech expand biosimilar deal, Keros gets Glass Lewis support, and GeNeuro receives debt moratorium.

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...